Login
Login

Author: Jim Potter

CHC_general1

IQVIA Drug Spending Report: OOP Costs Increasing, but Net Prices Rising Below Inflation

Learn More
CHC_DTCadvertisement2

Presentation of Risks in DTC Video, HCP Webpage Yields Enforcement Letter for Bausch Health

Learn More
CHC_general2

CMS Sticks to Plan: No Aduhelm Coverage Unless in Clinical Trial

Learn More
CHC_washingtonfocus2

Biden’s 2023 Budget: Big Increases for FDA, CDC, Pandemic Preparedness

Learn More
BannerAd.News

OPDP To Study DTC Website Promotion of Accelerated Approval Drugs

Learn More
CHC-Logo.300x300

Carter: CHC Plays Vital Role in Protecting our Industry

Learn More
CHC_Legislative1

House Shines Spotlight on Accelerated Approvals, May Tie Legislation to PDUFA

Learn More
Nancy Myers.NEWS

Myers: Data Will Drive Califf’s Decisions at FDA

Learn More
Rawson.News

Fallout from Aduhelm Decision Could Undermine FDA Accelerated Approval Process

Learn More